Clinical Trial Update: Iota-Carrageenan Nasal Spray in Common Cold [Phase 4]

View source ↗

Summary

Phase 4 trial results for iota-carrageenan nasal spray in the common cold have been posted. The study, sponsored by Boehringer Ingelheim, is now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Iota-Carrageenan Nasal Spray (iota-carrageenan nasal spray)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Common Cold | Phase 4 | Status: COMPLETED | Results posted: 2015-04-03